SCHEMBL9193057

SCHEMBL9193057

Nc1ccc(C(O)c2ccccc2F)cc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ POLB P06746 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ ADRB2 P07550 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39
▸ MAP2K1 Q02750 1/20 0.38
▸ HSPB1 P04792 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9198122 0.81 LMNA (0.51) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL10477443 0.80 TDP1 (0.49) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL9193954 0.74 CYP19A1 (0.50) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL7604891 0.73 TSHR (0.56) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL9527174 0.73 SMN1; SMN2 (0.53) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL31067515 0.73 SMN1; SMN2 (0.53) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL17064547 0.71 ALDH1A1 (0.45) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL31067424 0.71 ALDH1A1 (0.45) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL17064312 0.71 IDO1 (0.42) TDP1ALDH1A1CYP3A4CA1CA2
SCHEMBL31067420 0.71 IDO1 (0.42) TDP1ALDH1A1CYP3A4CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 — — EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 — — US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 — — US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 — — EP disclosed
Send feedback